← Evidence map

ReviewJournal of clinical and experimental hepatology

Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD.

Ajay Duseja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD. | OpenQuestion